Initial data from South Africa suggests mild breakthrough cases

Breakthrough case = infection after 2 x vaccine doses + 21 days. Currently breakthrough cases overwhelmingly mild which is good news. Not enough data to get a firm efficacy estimates just yet.

South Africa used Pfizer Biontech. Cant assume same outcome for those who received AZ.

Posted By: Timmy_Goat, Nov 28, 17:10:09

Reply to Message

Log in


Written & Designed By Ben Graves 1999-2024